Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction
application · Notice · Notice of application; correction. · Published 2020-03-10 · 85 FR 13931
Document
Document number
2020-04829
Federal Register citation
85 FR 13931
Type
Notice
Action
Notice of application; correction.
Category
application
Publication date
2020-03-10
Party named
S&B Pharma, Inc.; Correction
Abstract
The Drug Enforcement Administration (DEA) published a document in the Federal Register on November 22, 2019, concerning a notice of application. As that document correctly indicated, the applicant, S&B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a bulk manufacturer of a number of controlled substances, to include applying for authorization in order to synthetically manufacture using drug code 7360 (marihuana). However, on the notice of application published, drug code 7360 was inadvertently identified and listed as Gamma Hydroxybutyric Acid instead of Marihuana.